Europe Gastroparesis Market to Grow at a CAGR of 4.0% to reach US$ 1,683.42 million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Gastroparesis Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Gastroparesis Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing prevelance of Diabetes Mellitus

5.2 Market Opportunities

5.2.1 Surging Clinical Trials

5.3 Future Trends

5.3.1 Technological Advancements and incresaing research on gastric stimulation

5.4 Impact of Drivers and Restraints

6. Europe Gastroparesis Market Regional Analysis

6.1 Europe Gastroparesis Market Overview

6.2 Europe Gastroparesis Market Revenue 2018-2027 (US$ Million)

6.3 Europe Gastroparesis Market Forecast Analysis

7. Europe Gastroparesis Market Analysis – by Type

7.1 Idiopathic

7.1.1 Overview
7.1.2 Idiopathic: Europe Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Diabetic

7.2.1 Overview
7.2.2 Diabetic: Europe Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Post-Surgical

7.3.1 Overview
7.3.2 Post-Surgical: Europe Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents

8.1.1 Overview
8.1.2 Prokinetic Agents: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Botulinum Toxin Injections

8.2.1 Overview
8.2.2 Botulinum Toxin Injections: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Antiemetic Agents

8.3.1 Overview
8.3.2 Antiemetic Agents: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Antiemetic Agents: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Antiemetic Agents: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Gastroparesis Market – Europe Analysis

10.1 Europe

10.1.1 Europe Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
10.1.1.1 Europe Gastroparesis Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Gastroparesis Market Breakdown, by Type
10.1.1.1.2 UK: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.1.3 UK: Europe Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.2 Germany: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Gastroparesis Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.2.3 Germany: Europe Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Gastroparesis Market Breakdown, by Type
10.1.1.3.2 France: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.3.3 France: Europe Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.4 Russia: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Gastroparesis Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.4.3 Russia: Europe Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Gastroparesis Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.5.3 Italy: Europe Gastroparesis Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe: Europe Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Gastroparesis Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Gastroparesis Market Breakdown, by Drug Class
10.1.1.6.3 Rest of Europe: Europe Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Gastroparesis Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allergan Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ipca Laboratories Ltd.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson and Johnson Services, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Pfizer Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights